Skip Navigation
 
 
 
 
Wilmer Eye Institute
 
Print This Page
Share this page: More
 

Letter From the Director

McDonnell, PeterThe Wilmer Eye Institute has a long tradition in treatment and research related to macular degeneration. Wilmer was one of the first institutions in the country to use laser photocoagulation to treat choroidal neovascularization. It served as the coordinating center for the Macular Photocoagulation Study, a large multicenter clinical study that demonstrated that laser photocoagulation is beneficial for the small minority of patients with choroidal neovascularization whose eyes have the characteristics that make them eligible to receive it. Wilmer has continued to be the leading center in the country for clinical trials related to macular degeneration and is currently serving as the coordinating center for photodynamic therapy trials and the Submacular Surgery Trial. In addition, Wilmer surgeons have developed and are refining new surgical approaches, such as limited macular translocation. The Wilmer Eye Institute is also a leader in basic research related to macular degenerations. A large number of NIH-funded investigators are studying various aspects of the disease processes.

Despite this exemplary track record, at a recent retreat, the faculty decided that macular degeneration is such an enormous problem that we need to do more. It was decided to form the Wilmer Macular Degeneration Center (WMDC) to focus and strengthen our efforts aimed at finding a cure and alleviating the suffering of patients who are already affected.

The fight against macular degenerations is a major priority at the Wilmer Eye Institute. Through this web site, we seek to keep patients, family members, physicians, and scientists updated on new developments and resources that are available. I hope you enjoy your virtual tour of the Wilmer MDC.

— Peter J. McDonnell, M.D., Chairman & Director of the Wilmer Eye Institute

Dr. Sheila West on the Link Between Smoking and Eye Disease in Women - 7/23/2014

Dr. Pradeep Ramulu and Colleagues Study Relationship Between Vision Loss and Work Status - 7/18/2014

Wilmer Resident Receives Lindstrom Research Grant - 7/11/2014

Four Wilmer Researchers Receive BrightFocus Foundation Awards - 7/10/2014

Dr. Michael Repka Part of Team Researching Telemedicine and ROP - 6/27/2014

Dr. M. Valeria Canto-Soler and Colleagues Featured on WBAL-TV - 6/24/2014

Dr. M. Valeria Canto-Soler and Colleagues Use Human Stem Cells to Create Light-Sensitive Retina in a Dish - 6/10/2014

Wilmer's Division of Ocular Immunology Announces "Living With Uveitis" Support Group - 6/10/2014

Dr. Neil Bressler to Speak on Diabetic Retinopathy at National Eye Health Summit and Webcast - 6/10/2014

Dr. Donald Zack Receives a Research to Prevent Blindness Nelson Trust Award for Retinitis Pigmentosa - 6/9/2014

Dr. Michael Boland Leads Study on Effectiveness of Automated Telecommunication-Based Reminders on Adherence to Glaucoma Medication Dosing - 6/4/2014

Dr. Christina Prescott Discusses Summer Eye Protection on Fox 45 News - 6/1/2014

Dr. Jonathan Song Discusses Treatment Options for Pediatric Cataracts - 5/23/2014

Johns Hopkins' Jordan Green Discusses His Work at Wilmer's Translational Tissue Engineering Center - 5/21/2014

Longtime Wilmer Employee Lillie Alston Honored by Hopkins - 5/19/2014

Dr. Richard Semba: Diets Rich in Antioxidant Resveratrol Fail to Reduce Deaths, Heart Disease or Cancer - 5/12/2014

Dr. Neil Miller Explains Eye Twitching in The Wall Street Journal - 5/12/2014

Dr. Hendrik Scholl Receives ARVO Award - 5/7/2014

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer